Stock Comparison

OBIO vs AAPL

Side-by-side fundamentals, quality, value, and price momentum analysis.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Quick presets:

Metrics Comparison

Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.

MetricOBIOOrchestra BioMed Holdings, Inc.AAPLApple Inc.
Market Cap$235.46M$3.8T
Current Price$4.17$258.21
P/E Ratio-2.5134.61
Revenue Growth 1Y-4.4%6.4%
Net Margin-23.1%26.9%
ROE-120.8%171.4%
ROIC-145.3%70.6%
Debt/Equity0.501.34
FCF Yield2.6%
Dividend Yield0.4%
Loading chart...

OBIO vs AAPL: Key Questions Answered

Which stock is growing the fastest: OBIO or AAPL?

Apple Inc. (AAPL) is growing the fastest with 6.4% revenue growth. Orchestra BioMed Holdings, Inc. has the slowest growth at -4.4%. Higher growth often justifies higher valuations.

Which has the best profit margins: OBIO or AAPL?

Apple Inc. (AAPL) has the strongest profitability with a 26.9% net margin. Orchestra BioMed Holdings, Inc. has the lowest at -23.1%. Higher margins indicate pricing power and efficiency.

Which is the largest company: OBIO or AAPL?

Apple Inc. (AAPL) is the largest company with a market cap of $3.80T. Orchestra BioMed Holdings, Inc. is the smallest at $0.2B. Larger companies tend to be more stable but may have less growth potential.

Which stock has the best return on equity: OBIO or AAPL?

Apple Inc. (AAPL) generates the best returns on shareholder equity with an ROE of 1.7%. Orchestra BioMed Holdings, Inc. has the lowest at -1.2%. Higher ROE indicates efficient use of capital.